At MSACL 2016, Extra Attention on Mass Spec-Based Dx | GenomeWeb

PALM SPRINGS, CALIFORNIA (GenomeWeb) – The 2016 edition of the Mass Spectrometry: Applications to the Clinical Lab US (MSACL) conference highlighted the continued challenges of aligning the technology with the broader agenda of the diagnostics field.

The mass spec-based diagnostics field is like a water balloon; it is set to be squeezed on one end by impending regulation of laboratory-developed tests, but also to expand as matrix-assisted laser desorption/ionization (MALDI) mass spec platforms gain greater adoption in the clinical market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.